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Compartmentalized Connexin 43 S-Nitrosylation/
Denitrosylation Regulates Heterocellular Communication in
the Vessel Wall
Adam C. Straub, Marie Billaud, Scott R. Johnstone, Angela K. Best, Sean Yemen, Scott T. Dwyer,
Robin Looft-Wilson, Jeffery J. Lysiak, Ben Gaston, Lisa Palmer, Brant E. Isakson
Objective—To determine whether S-nitrosylation of connexins (Cxs) modulates gap junction communication between
endothelium and smooth muscle.
Methods and Results—Heterocellular communication is essential for endothelium control of smooth muscle constriction;
however, the exact mechanism governing this action remains unknown. Cxs and NO have been implicated in regulating
heterocellular communication in the vessel wall. The myoendothelial junction serves as a conduit to facilitate gap
junction communication between endothelial cells and vascular smooth muscle cells within the resistance vasculature.
By using isolated vessels and a vascular cell coculture, we found that Cx43 is constitutively S-nitrosylated on cysteine
271 because of active endothelial NO synthase compartmentalized at the myoendothelial junction. Conversely, we found
that stimulation of smooth muscle cells with the constrictor phenylephrine caused Cx43 to become denitrosylated
because of compartmentalized S-nitrosoglutathione reductase, which attenuated channel permeability. We measured
S-nitrosoglutathione breakdown and NOx concentrations at the myoendothelial junction and found S-nitrosoglutathione
reductase activity to precede NO release.
Conclusion—This study provides evidence for compartmentalized S-nitrosylation/denitrosylation in the regulation of
smooth muscle cell to endothelial cell communication. (Arterioscler Thromb Vasc Biol. 2011;31:399-407.)
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Within the vessel wall of resistance arteries, coordinatedvascular smooth muscle cell (SMC) and endothelial
cell (EC) function is integrated by complex intercellular
signaling to regulate the constriction and dilation of the
artery. The anatomic structures that facilitate direct SMC and
EC communication within the resistance artery are myoen-
dothelial junctions (MEJs), which are cellular extensions
from ECs or SMCs that project through the internal elastic
lamina1–3 and link the plasma membranes of the 2 different
cell types together. The gap junctions (GJs) at the MEJ
provide a conduit for second messenger and electric signaling
between the 2 cell types.2,4,5 For example, phenylephrine (PE)
stimulation of SMCs induces inositol 1,4,5-triphosphate (IP3)
generation and an increase in [Ca2]i concentrations, con-
stricting the artery. It is thought that the IP3 progresses to the
adjacent EC through GJs at the MEJ, initiating an increase in
[Ca2]i and the release of NO to modulate the magnitude of
vasoconstriction, thereby regulating the tone of the artery.6–8
Elucidation of the mechanisms regulating this process could
provide novel insight into blood pressure regulation; how-
ever, the process remains uncharacterized.
GJs are intracellular signaling channels formed by 2
hexameric hemichannels, with each adjacent cell contributing
1 hemichannel. Connexin (Cx) proteins compose the chan-
nels, of which 4 different Cxs have been identified in the
vasculature, with multiple studies demonstrating a potentially
important role for Cx43 at the MEJ.9 Recent studies have
demonstrated that GJ communication and trafficking of Cx43
are modulated by caveolae10–12 and caveolin-1,13 supporting
the observation that caveolin-1 could regulate Cx43 traffick-
ing to the MEJ.14 In addition to regulating Cx43, caveolin-1
also regulates, mobilizes, and organizes several proteins,
including endothelial NO synthase (eNOS).14–17 Although
eNOS has not been shown at the MEJ, it is possible that it
resides in this location because of the caveolae-rich
environment.
NO participates in a plethora of physiological functions
within the vessel wall, including vasodilation18 and posttrans-
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lational protein S-nitrosylation.19 S-nitrosylation has emerged
as a key mechanism by which NO may influence the
function of a wide array of cellular proteins by covalently
modifying sulfhydryl groups on cysteine residues both in
vivo and in vitro.20,21 Despite its high ability to diffuse,
growing evidence22,23 supports the concept that NO is
generated locally; however, more important, this occurs in a
concentration-dependent manner to elicit specific protein
S-nitrosylation. Indeed, maintaining a critical balance be-
tween normal physiological protein S-nitrosylation and pro-
tein denitrosylation is essential.24 One enzyme involved in
regulating the balance between protein S-nitrosylation/deni-
trosylation is S-nitrosoglutathione reductase (GSNOR).24
GSNOR indirectly regulates the levels of S-nitrosylated
proteins by reducing GSNO, thereby providing equilibrium
between S-nitrosylated proteins and GSNO.25,26 Indeed, mice
deficient in GSNOR and in vitro studies have confirmed that
GSNOR mediates multiple cardiovascular functions.24,27,28
In this study, we provide evidence of an eNOS/GSNOR
axis that regulates compartmentalized S-nitrosylation/deni-
trosylation of Cx43 permeability at the MEJ, thereby altering
the constriction and dilatory response of a resistance artery.
We propose that the specific cellular localization of proteins
capable of dynamic S-nitrosylation/denitrosylation may be a
template for heterocellular communication in general.
Methods
Thesupplementalmaterials(availableonlineathttp://atvb.ahajournals.
org) provide expanded descriptions.
Mice
Wild-type mice, strain C57Bl/6 (Taconic), GSNOR/, and
GSNOR/ (originally described by Liu et al24), were all males aged
approximately 8 to 10 weeks and were used according to the
University of Virginia Animal Care and Use Committee (Charlottes-
ville) guidelines.
Vessel Cannulation
Mice were euthanized with an intraperitoneal injection of pentobar-
bital (60 to 90 mg/kg). First-order thoracodorsal (TD) arteries, a pair
of resistance arteries (diameter, approximately 245 m) with exten-
sive MEJs and endothelium-dependant hyperpolarization that sup-
plies blood to spinotrapezius muscle (supplemental Figure I), were
isolated for cannulation.29,30
Immunolabeling on Transmission Electron
Microscopy Sections
TD arteries and cremaster, coronary, and mesentery vessels were
isolated and processed for immunogold labeling and quantified as
previously described.31
Cell Culture, Isolation of In Vitro MEJ Fractions,
and Biotin Switch Assay
The vascular cell coculture (VCCC) was constructed as previously
described.4
In vitro MEJ fractions were isolated from the VCCC as previously
described.31
Isolated EC, MEJ, and SMC fractions were subjected to the biotin
switch assay as previously described.32,33
Immunoblots, Immunostaining, and Antibodies
Proteins were resolved using 4% to 12% bis-Tris gels, transferred to
nitrocellulose, and visualized and analyzed using an imager (Li-Cor
Odyssey Imager), as previously described.34
Immunostaining on frozen sections of VCCC and HeLa cells was
performed as previously described.35 All images were captured using
a confocal microscope (Fluoview 1000).
Data on antibody source, application, concentration, and company
of purchase are found in supplemental Table I.
Statistics
Statistics were performed using computer software (Origin Pro 6.0).
All experiments were analyzed using 1- or 2-way ANOVA, followed
by the Bonferroni posttest for differences between treatments where
indicated. P0.05 was considered significant.
Results
NO and GJs Regulate
Heterocellular Communication
As demonstrated in Figure 1A, the stimulation of a control
TD artery with PE induces an initial constriction, followed by
a redilation to bring the vessel back to near resting tone. We
believe that this response is because of heterocellular com-
munication between the SMCs and the ECs, specifically the
generation of a second messenger by PE in SMCs (eg, IP3 or
constriction), which traverses GJs at the MEJ to activate
eNOS in the ECs (redilation). For this reason, we initially
tested a GJ inhibitor (carbenoxylone, Figure 1A) and an NOS
inhibitor (L-Nitro-Arginine Methyl Ester [L-NAME], Figure
1B) and found them both capable of significantly enhancing the
constriction and inhibiting the redilation response. Because these
data indicated that both Cxs and eNOS might be important
regulators for intercellular communication between SMCs and
ECs, we used transmission electron microscopy (TEM) and
quantified the amount of Cx43 and eNOS present in the TD
artery (Figure 1C and 1D). Cx43 was the only Cx enriched at
MEJs (supplemental Figure IIA), indicating that it is likely a
major contributor of GJ heterocellular communication from
SMCs to ECs. This observation was also seen at the in vitro
MEJ.31 The presence of eNOS was also localized to the MEJ
(Figure 1D), a trend we found throughout vascular beds (sup-
plemental Figure IIB). Normal rabbit serum confirmed the
specificity of our gold bead staining (supplemental Figure IIC).
By using the VCCC, we also identified localized eNOS to the in
vitro MEJ (Figure 1E and 1F). In contrast, neuronal NO synthase
expression in TD MEJs (supplemental Figure IID through IIF),
inducible NO synthase (supplemental Figure IIG through III), or
another vasodilatory enzyme (cystathionine, supplemental. Fig-
ure IIJ through IIL) was not detected. Last, we observed
caveolin-1, a protein capable of trafficking both eNOS and
Cx43,10–17 as being localized at the MEJ in TD arteries and in
the VCCC (supplemental Figure IIIA through IIIE).
Although eNOS was identified at the MEJ in vivo and in
vitro, this was not indicative of its activity. Therefore, we applied
L-NAME to vessels, measured resting tone in the absence of an
agonist, and found a significant constriction (Figure 2A). These
data coincided with the localization of phosphorylated S1177
eNOS at the MEJ in vivo and in vitro (Figure 2B and 2C) in the
absence of any agonist. Phosphorylated S633 eNOS (active) was
also observed at MEJs in vitro; however, phosphorylated T495
eNOS (inactive) was not observed (Figure 2D and 2E).
S-Nitrosylation of Cx43 on C271 Regulates
GJ Communication
Because our ex vivo and in vitro evidence demonstrated basally
active eNOS and the presence of Cx43 at the MEJ, the capacity
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of Cx43 to be S-nitrosylated was tested. Initial studies confirmed
Cx43 to be constitutively S-nitrosylated in isolated TD arteries
and at the in vitro MEJ (Figure 3A), whereas Cx40, a Cx found
at the MEJ in some instances, was not S-nitrosylated (supple-
mental Figure IVA). To identify which cysteines may be
responsible for S-nitrosylation, we used HeLa cells (which do
not express Cxs or eNOS) and transfected in either Cx43 or
Cx43 with all of the cysteines in the C-terminal mutated to
alanines (Cx43C260/271/298A). After treatment of transfected HeLa
cells with GSNO, S-nitrosylated Cx43 was only detected in the
nonmutated sample (Figure 3B). This was repeated on purified
Cx43 C-terminal36 and Cx43C260/271/298A C-terminal peptides,
which produced identical results to Cx43 proteins expressed in
HeLa cells (Figure 3C). Thus, to identify whether S-nitrosylation
was site specific, we generated Cx43 containing only 1
C-terminal cysteine. After GSNO treatment, only Cx43C260/298A
was S-nitrosylated, indicating that C271 in the Cx43 C-terminal
was the target for S-nitrosylation of Cx43 (Figure 3D). Func-
tional changes as a result of S-nitrosylation were then tested in
HeLa cells transfected with cysteine mutants by measuring the
extent of Ca2 wave propagation after uncaging of P(4(5))-1-
(2-nitrophenyl)ethyl (NPE)-IP3. Calcium propagation rates were
increased in response to GSNO for both Cx43 and Cx43C260/298A
cells but unchanged in Cx43C260/271A-, Cx43C271/298A-, and
Cx43C260/271/298A-expressing cells (Figure 3E). HeLa cells trans-
fected without Cx43 did not propagate Ca2 waves after
pseudouncaging (supplemental Figure IVB). The differences in
calcium wave propagation did not result from trafficking defects
of the Cx43 mutations because all were effectively localized to
the plasma membrane (supplemental Figure IVC through IVH).
These data indicate that Cx43 and its GJ function are capable of
being regulated by S-nitrosylation at C271.
Compartmentalized Denitrosylation of Cx43 at
the MEJ
Because our previous results had demonstrated that Cx43 was
extensively expressed at the MEJ and had the capacity to be
S-nitrosylated, we tested whether PE stimulation could alter
Cx43 S-nitrosylation. By using isolated TD arteries, we found
a reduction in S-nitrosylation of Cx43 3 minutes after PE
Figure 1. Vasoreactivity is altered by
inhibition of GJ communication and NO
correlating with Cx43 and eNOS expres-
sion at the MEJ. Mouse TD arteries were
cannulated, pressurized, and stimulated
with 50-mol/L PE. A and B, Application
of carbenoxolone (50 mol/L, A) and
L-NAME (100 mol/L, B) significantly
enhanced PE-induced vasoconstriction
in the TD arteries. C and D, Immuno-
TEM analysis of Cx43 (C) and eNOS (D)
localization labeled with 10-nm gold
beads (arrows) at MEJs from the TD
arteries quantified the number of beads
per micrometer squared. E, Isolated EC,
MEJ, and SMC protein fractions from
the VCCC blotted for eNOS and normal-
ized to GAPDH. F, Immunocytochemistry
of transverse sections from a VCCC
were labeled for eNOS (green). The
white box illustrates an enlarged MEJ
with a line scan measuring fluorescence
down the pore. Data are represented as
the meanSE. (C, n8; D, n6; E,
n4). Significant differences (*P0.05)
were analyzed using a 2-way ANOVA (A
and B) or a 1-way ANOVA (C-E). In A
and B, n is the number of vessels and
the value in parentheses is the number
of mice. E indicates endothelial cell; IEL,
internal elastic lamina; S, smooth muscle
cell; *, lumen. The scale bar in C and D
is 0.5 m; and F, 10 m. In C through E,
the open bars indicate in vitro measure-
ments; and bars with horizontal lines, in
vivo measurements.
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stimulation, which returned to baseline after 10 minutes
(Figure 4A). This result indicated that, in vivo, Cx43 at the
MEJ is likely S-nitrosylated. Concurrent with this result,
denitrosylation of Cx43 was only observed at the MEJ, and
not the EC or SMC monolayer (Figure 4B), indicating a
highly localized denitrosylation response (an effect identical
to that seen on silver-stained gels of total S-nitrosylated
proteins after PE stimulation) (supplemental Figure VA
through VC). Neither application of 18GA (supplemental
Figure VD) nor the UV used for uncaging (supplemental
Figure VE) altered Cx43 S-nitrosylation. To test whether
denitrosylation of Cx43 correlated with changes in channel
permeability, we stimulated SMCs on the VCCC with PE and
then temporally uncaged NPE-IP3 (Figure 4C). Under control
conditions, uncaging of NPE-IP3 in the SMCs elicited a
robust increase in EC [Ca2]i, which was significantly
inhibited by the GJ blocker (18GA, Figure 4D). At 1 minute
after PE stimulation, there was a significant reduction in EC
Figure 2. eNOS is differentially phos-
phorylated at the MEJ. Mouse TD arter-
ies were cannulated and pressurized. A,
The basal vascular tone was attenuated
in the presence of L-NAME (100 mol/
L). B, Phosphorylated eNOS S1177
localization using 10-nm gold beads
(arrow) in TD arteries using immuno-TEM
and quantified as the number of beads
per micrometer squared. C through E,
Isolated EC, MEJ, and SMC fractions
from the VCCC blotted for phosphorylated
eNOS at sites S1177, S633, and T495 in
EC, MEJ, and SMC fractions. Data are
represented as the meanSE. (A, n5;
B-E, n4). Significant differences
(*P0.05) were analyzed using a 1-way
ANOVA (A–D). E, endothelial cell; IEL,
internal elastic lamina; S, smooth muscle
cell; *, lumen. The scale bar is 0.5 m (B).
In A through E, open bars indicate in vitro
measurements; and bars with horizontal
lines, in vivo measurements.
Figure 3. Cx43 is S-nitrosylated on cys-
teine 271. A, Unstimulated TD arteries
or MEJ fractions analyzed by the biotin
switch assay for Cx43, in which
ascorbate-dependent labeling demon-
strates the presence of an S-nitrosylated
cysteine residue(s). B, Nontransfected
and transfected HeLa cells with Cx43 or
Cx43C260/271298A were treated with or
without 100-mol/L GSNO for 1 hour.
C, Biotin switch assay of purified
Cx43 C-terminal or Cx43C260/271298A
C-terminal peptides treated with or with-
out 100-mol/L GSNO for 1 hour. D,
HeLa cells transfected with Cx43C260/271A,
Cx43C260/298A, or Cx43C271/298A and
treated with 100-mol/L GSNO for 1
hour were lysed and subjected to the
biotin switch assay. E, Uncaging of NPE-
IP3 and analysis of calcium wave propa-
gation and transfected HeLa cells with
Cx43, Cx43C260/271/298A, Cx43C260/271A,
Cx43C260/298A, and Cx43C271/298A. Data
are represented as the meanSE (n6
to 8). Significant differences (*P0.05)
were analyzed using a 1-way ANOVA.
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[Ca2]i, which returned to control levels at 20 minutes after
PE stimulation. This suggested that the permeability of the GJ
channel immediately after PE stimulation was decreased,
which was likely because of a loss of Cx43 S-nitrosylation.
GSNOR Denitrosylates Cx43 at the MEJ
Because of the rapid denitrosylation of Cx43 at the MEJ on
PE stimulation, we hypothesized that an enzyme capable of
denitrosylating proteins may also be localized to the MEJ.
Probing for GSNOR, we found the enzyme to be enriched in
MEJ fractions both in vitro and in vivo (Figure 5A through
5C). In contrast, other enzymes known to denitrosylate
proteins, thioredoxin-1,37 and carboxyl reductase38 were not
present at the MEJ (supplemental Figure VIA through VIC).
Next, we tested the activity of GSNOR after PE stimulation
specifically in MEJ fractions and found increased activity at
1 minute, which returned to baseline after 20 minutes (Figure
5D). From the same MEJ lysates, we also measured total NOx
and found a significant increase at 20 minutes compared with
control and 1 minute (Figure 5E), suggesting that GSNOR
activity precedes NO release. To test the effect of GSNOR
activity on Cx43 denitrosylation and GJ permeability at the
MEJ, we used the GSNOR inhibitor that was identified in a
high-throughput screen for GSNOR inhibitors and thereby
arbitrarily named C3.28 We found a complete lack of Cx43
denitrosylation after PE stimulation (Figure 5F), a result that
was similar to the result obtained using GSNOR small-
interfering RNA (supplemental Figure VIIA and VIIB).
Consistent with lack of denitrosylation after inhibiting
GSNOR, application of C3 did not alter GJ permeability of
IP3 from SMCs to ECs when compared with control (Figure
5G). TD arteries treated with C3 had an attenuated constric-
tion after application of PE (Figure 5H). The C3 did not alter
baseline artery diameter during equilibration (supplemental
Figure VIIC). The GSNOR/ mice were also less respon-
sive to PE (Figure 5I), which was dependent on NOS activity
and not S-nitrosothiols (supplemental Figure VIID). Last, the
GSNOR/ mice were not different from controls (supple-
mental Figure VIIE), a result that is due to compensatory
increases in carboxyl reductase in the TD arteries (supple-
mental Figure VIIF).
Discussion
Highly coordinated EC and SMC cross talk regulates vessel
diameter and, by extension, the blood flow rate and blood
pressure. GJs positioned at the MEJ between ECs and SMCs
in resistance arteries allow for signals (eg, IP3) originating
from 1 cell type (eg, SMCs) to rapidly diffuse to adjacent
cells (eg, ECs). Although GJs have been identified at the
MEJ, the specific mechanisms that regulate GJ communica-
tion at the MEJ remain largely unknown. We define a pivotal
posttranslational mechanism that ECs and SMCs use to
regulate heterocellular communication before, during, and
after SMC constriction. Our mechanism consists of compart-
mentalized S-nitrosylation/denitrosylation of Cx43 at the
MEJ to regulate the magnitude of vasoconstriction (Figure 6).
Figure 4. PE promotes denitrosylation of Cx43
and alters channel permeability. A and B, Immuno-
blots of isolated TD arteries or EC, MEJ, and SMC
fractions identifying S-nitrosylated Cx43 using the
biotin switch assay from VCCCs stimulated with
PE. C, Schematic illustration of the experimental
protocol used for measuring EC [Ca2]i using an
initial stimulus of PE, followed by uncaging of
NPE-IP3 in SMCs using UV flash at specific points
after PE stimulation. D, The maximum values of
EC [Ca2]i were measured at control, 0, 1, and 20
minutes after PE stimulation or with the addition of
18GA. Data are represented as the meanSE
(n3). Significant differences (*P0.05) were ana-
lyzed using a 1-way ANOVA. Open bars in B indi-
cate in vitro experiments.
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Several compelling observations support this discovery: (1)
eNOS is enriched and active at the MEJ, (2) Cx43
S-nitrosylation on cysteine 271 regulates more permeable GJ
channels, and (3) compartmentalized GSNOR denitrosylates
Cx43, promoting less permeable GJs at the MEJ to
modulate the movement of IP3 (and potentially other
factors). The cellular, pharmacological, and genetic results
presented herein imply that oxidation-reduction– based
protein modifications on site-specific cysteine residues are
regulated in specific regions of cells to coordinate hetero-
cellular communication.
SMC relaxation after PE-induced constriction is thought to
be due to IP3 movement from SMCs, through GJs at the MEJ,
to ECs.7 There is evidence to indicate that the IP3 activates
IP3 receptor 1 localized to the MEJ35 and induces an elevation
of EC [Ca2]i, thereby activating eNOS and releasing NO to
induce subsequent vasodilation.6,7,39 Our observation of Cx43
and active eNOS being localized to the MEJ provides the
proteins necessary for a regulatable mechanism. This is
supported by the observation that caveolae and caveolin-1
localize to the MEJ, thereby providing an optimal microsig-
naling domain whereby binding partners, including Cx43,
eNOS, and many other proteins, could cluster.10–17,35,40 In-
deed, spatial partitioning of proteins within a cell provides an
important level of control to ensure fidelity of cell signaling.
Accumulating evidence from monolayers of cultured cells
has suggested that localized eNOS could allow for NO to be
generated in a specific cellular region.22,23 It is reasonable to
speculate that the active pool of eNOS we observe at the MEJ
is regulating basal vascular tone and blood pressure because
we show, with L-NAME, induced constriction in Figure 2.
This would provide an energy-efficient mechanism to
minimize NO diffusion distance to the SMCs. Thus, our
identification of a pool of compartmentalized active eNOS
uniquely at the MEJ throughout different vascular beds
places these initial descriptive observations into a physio-
logical context.
Our data go beyond the possibility of paracrine release of
NO at the MEJ mediating the magnitude of vasoconstriction
and suggest another function for the pool of localized eNOS
Figure 5. GSNOR regulates heterocellu-
lar communication. A, Quantitative West-
ern blot analysis of GSNOR expression
in isolated EC, MEJ, and SMC protein
fractions from the VCCC normalized to
GAPDH. Immunocytochemistry of trans-
verse sections of a VCCC labeled for
GSNOR (red). B, The white box illus-
trates an enlarged MEJ with a line scan
measuring fluorescence down the pore.
C, Immuno-TEM analysis of GSNOR
expression labeled with 10-nm gold
beads (arrows) at MEJs from the TD
arteries and quantified as the number of
beads per micrometer squared. D, Mea-
surement of GSNOR activity by break-
down of GSNO in MEJ fractions at 1
and 20 minutes after PE stimulation. E,
Identification of total NOx in MEJ frac-
tions at 1 and 20 minutes after PE stim-
ulation. F, Immunoblot of S-nitrosylated
Cx43 from in vitro MEJ fractions pre-
treated with C3 inhibitor and then stimu-
lated with PE for 0, 1, 5, 10, and 20 min-
utes. G, Measurement of maximum
values of EC [Ca2]i after UV uncaging is
plotted at 0, 1, and 20 minutes after PE
stimulation from the VCCCs pretreated
with C3. H and I, Vasoconstriction
response measuring percentage change
of initial diameter to PE in TD arteries
pretreated with C3 in wild-type mice (H)
and GSNOR/ mice (I). Data are repre-
sented as the meanSE. (A, n5; C,
n5; E, n2; and F, n3). In H and I, n
is the number of vessels and the value in
parentheses is the number of mice. Sig-
nificant differences (*P0.05) were ana-
lyzed using a 1-way (E-G) or a 2-way
(H-I) ANOVA. The scale bar in B is
10 m; and in C, 0.5 m. E indicates
endothelial cell; IEL, internal elastic lam-
ina; S, smooth muscle cell; *, lumen.
Open bars indicate in vitro measure-
ments (A, E, and F); and bars with hori-
zontal lines, in vivo measurements (C).
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at the MEJ (ie, regulation of GJ-mediate intracellular com-
munication by NO). There are sporadic reports that NO could
alter the function of GJ channels. For example, NO reduced
Cx37 permeability and electric coupling in microvascular
cells,41,42 whereas other reports43,44 suggest that NO enhances
Cx43 electric current. However, this study used NO donors
and did not explore how NOS-derived NO may posttransla-
tionally modify the channel. It is becoming increasingly
clear that S-nitrosylation is a critical posttranslational
modification that regulates protein function.20,21 Our study
demonstrates that NO derived from eNOS at the MEJ
constitutively S-nitrosylates Cx43 in unstimulated condi-
tions in TD arteries and in the VCCC, thereby maintaining
a more permeable GJ channel. These data correlate with
recent reports43,44 that NO acts on Cx43 hemichannels (not
intact GJs) via S-nitrosylation to induce a more permeable
state. Although the exact cysteines were not identified,
these reports did show that the cysteines were more likely
intracellular than extracellular. Therefore, we created sev-
eral point mutations on the C-terminal of Cx43 and
identified C271 as the critical site that significantly en-
hanced calcium wave propagation after IP3 uncaging. The
sum of these data indicates that Cx43 S-nitrosylation on
C271 enhances permeability of the GJ channel; this can
occur in a discreet cellular compartment.
Although the aggregate of our work indicated that
S-nitrosylation maintained a more permeable GJ channel, it
was reasonable to propose that denitrosylation of Cx43
modulated a less permeable GJ channel. Remarkably, we
observed that denitrosylation after PE stimulation was con-
fined to the MEJ rather than the EC or SMC monolayer. Of
the multiple enzymes that have regulated denitrosylation,
including GSNOR/GSNO,24,45 thioredoxin-1 reductase/
thioredoxin-1,37 and carboxyl reductase,38 we found that
GSNOR was the dominant enzyme localized at the MEJ. This
was evident because GSNOR activity specifically at the MEJ
increased immediately after PE stimulation, which returned to
baseline after 20 minutes. Conversely, we found that NOx
was increased only at the 20-minute point, supporting the idea
that GSNOR activity precedes eNOS activity. It is unknown
how GSNOR activity is regulated, although one likely pos-
sibility is through a Ca2-dependent signaling pathway based
on the rapid IP3-induced increase in EC [Ca2]i and the
immediacy of the effect. The pharmacological and genetic
approaches in this study also support that GSNOR regu-
lates denitrosylation at the MEJ. In cannulated vessels, C3
and GSNOR/ mice both had severely attenuated con-
striction. It is not clear how this occurs, but based on the
data from the VCCC, we believe this is due to the
enhanced GJ permeability, allowing for greater IP3 transfer
from SMCs to ECs enhancing eNOS-derived NO. Previous
studies24,28 have demonstrated that inhibition of GSNOR
increases S-nitrosothiols, thereby promoting SMC relax-
ation. However, our model system does not support this
because L-NAME increased the magnitude of the constric-
tion in cannulated vessels. Rather, these data confirm that
NOS activity is a critical modulator of SMC constriction.
These observations underpin the central role that compart-
mentalized GSNOR plays in regulating heterocellular
communication in the artery wall.
In summary, results from this study emphasize the critical
role that S-nitrosylation/denitrosylation contributes to hetero-
cellular communication. Specifically, the evidence provided
herein supports multiple roles for eNOS at the MEJ, including
the following: (1) basal release of NO for regulating vaso-
motor tone and blood pressure, (2) local S-nitrosylation of
Figure 6. Schematic summary of Cx43 S-nitrosylation/denitrosylation regulating heterocellular communication in the vessel wall. Appli-
cation of PE stimulates the 1 receptor (1), followed by the induction of IP3 release in SMCs (2). The release of IP3 activates intracellu-
lar calcium stores in endoplasmic reticulum promoting SMC contraction (3). In addition, IP3 traverses S-nitrosylated Cx43 GJ channels
at the MEJ to stimulate IP3 receptors in ECs, inducing calcium release (5). GSNOR activity increases (6), which promotes denitrosyla-
tion of Cx43, altering channel permeability (7). Calcium and phosphorylation activate eNOS, resulting in released NO (8) to promote
SMC relaxation and renitrosylation of Cx43 to open GJ channels (9).
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Cx43 to regulate more permeable channels, and (3) local
production of NO for immediate feedback on SMCs. The
presence of GSNOR provides a check on this system by
inducing Cx43 denitrosylation on constriction and inducing a
less permeable GJ. The results provide an investigational
framework for future endeavors focusing on the eNOS/
GSNOR axis as a potential therapeutic target for treating
vascular pathological features, such as hypertension.
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